Viral loads among HIV-infected persons diagnosed with primary and secondary syphilis in 4 US cities: New York City, Philadelphia, PA, Washington, DC, and Phoenix, AZ

Journal of Acquired Immune Deficiency Syndromes

Volumn 70, Issue 2, 2015, Pages 179-185

  Taylor, Melanie M ^a,b,c   Newman, Daniel R ^a   Schillinger, Julia A ^a,d   Lewis, Felicia M T ^a,e   Furness, Bruce ^a,f   Braunstein, Sarah ^d   Mickey, Tom ^d   Skinner, Julia ^b   Eberhart, Michael ^e   Opoku, Jenevieve ^f   Blank, Susan ^a,d   Peterman, Thomas A ^a  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^b ARIZONA DEPARTMENT OF HEALTH SERVICES   (United States)

^c STD Program   (United States)

^d NEW YORK CITY DEPARTMENT OF HEALTH AND MENTAL HYGIENE   (United States)

^e PHILADELPHIA DEPARTMENT OF PUBLIC HEALTH   (United States)

^f District of Columbia Department of Health   (United States)

Author keywords

HIV; HIV transmission; HIV treatment; Men who have sex with men; STD HIV coinfection; Syphilis; Viral load

Indexed keywords

ADOLESCENT; ADULT; AFRICAN AMERICAN; ARTICLE; CD4 LYMPHOCYTE COUNT; CONTROLLED STUDY; CORRELATIONAL STUDY; DISEASE SURVEILLANCE; FEMALE; HISPANIC; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; PRIMARY SYPHILIS; PRIORITY JOURNAL; REGISTER; SECONDARY SYPHILIS; SYPHILIS; UNITED STATES; URBAN AREA; VIRUS LOAD; YOUNG ADULT; COMPLICATION; HIV INFECTIONS; VIROLOGY;

ADOLESCENT; ADULT; FEMALE; HIV INFECTIONS; HUMANS; MALE; MIDDLE AGED; SYPHILIS; UNITED STATES; VIRAL LOAD; YOUNG ADULT;

EID: 84942052202     PISSN: 15254135     EISSN: 10779450     Source Type: Journal    
DOI: 10.1097/QAI.0000000000000730     Document Type: Article

References (48)

1. Centers for Disease Control and Prevention. Estimated HIV incidence in the United States, 2007-2010. HIV AIDS Surveill suppl rep. 2012; 17. Available at: http://www.cdc.gov/hiv/topics/surveillance/resources/reports/#supplemental. Accessed May 28, 2013.
2. Prejean J, Song R, Hernandez A, et al. Estimated HIV incidence in the United States, 2006-2009. PLoS One. 2011; 6: e17502.
3. Brewer TH, Schillinger J, Lewis FM, et al. Infectious syphilis among adolescent and young adult men: implications for human immunodeficiency virus transmission and public health interventions. Sex Transm Dis. 2011; 38: 367-371.
4. Heffelfinger JD, Swint EB, Berman SM, et al. Trends in primary and secondary syphilis among men who have sex with men in the United States. Am J Public Health. 2007; 97: 1076-1083.
5. Torrone EA, Bertolli J, Li J, et al. Increased HIV and primary and secondary syphilis diagnoses among young men-United States, 2004-2008. J Acquir Immune Defic Syndr. 2011; 58: 328-335.
6. Su JR, Weinstock HS. Epidemiology of co-infection with HIV and syphilis in 34 states, United States, 2009. Abstract 1874. Paper presented at: National HIV Prevention Conference; August, 2011, Atlanta, GA.
7. Pathela P, Braunstein SL, Schillinger JA, et al. Men who have sex with men have a 140-fold higher risk for newly diagnosed HIV and syphilis compared with heterosexual men in New York city. J Acquir Immune Defic Syndr. 2011; 58: 408-416.
8. Peterman TA, Newman DR, Maddox L, et al. High risk for HIV following syphilis diagnosis among men in Florida, 2000-2011. Public Health Rep. 2014; 129: 164-169.
9. Huhn GD, McIntyre AF, Broad JM, et al. Factors associated with newly diagnosed HIV among persons with concomitant sexually transmitted diseases. Sex Trans Dis. 2008; 35: 731-737.
10. Pathela P, Braunstein SL, Shepard C, et al. Population-based HIV incidence among men diagnosed with infectious syphilis, 2000-2011. Abstract presentation. Paper presented at: International Society of STD Research Meeting; July 14-17, 2013; Vienna, Austria.
11. Fleming D, Wasserheit J. From epidemiological synergy to public health policy and practice: the contribution of other sexually transmitted diseases to sexual transmission of HIV infection. Sex Transm Infect. 1999; 75: 3-17.
12. Cope A, Crooks A, Kuruc J, et al. Sexually transmitted infection incidence as a biomarker for high risk sexual behavior in individuals diagnosed with acute HIV after entering care. Abstract TUPDC0105. Paper presented at: International AIDS Conference; July 22-27, 2012; Washington, DC.
13. Hague JC, Muvva R, Miazad RM. STD coinfection and reinfection following HIV diagnosis: evidence of continued sexual risk behavior. Sex Transm Dis. 2011; 38: 887-888.
14. Mayer KH, Bush T, Henry K, et al. Ongoing sexually transmitted disease acquisition and risk-taking behavior among US HIV-infected patients in primary care: implications for prevention interventions. Sex Transm Dis. 2012; 39: 1-7.
15. Cohen MS, Chen YQ, McCauley M, et al. Prevention of HIV-1 infection with early antiretroviral therapy. N Engl J Med. 2011; 365: 493-505.
16. Hoover KW, Butler M, Workowski K, et al. STD screening of HIVinfected MSM in HIV clinics. Sex Transm Dis. 2010; 37: 771-776.
17. Centers for Disease Control and Prevention. Incorporating HIV prevention into the medical care of persons living with HIV: recommendations of CDC, the Health Resources and Services Administration, the National Institutes of Health, and the HIV Medicine Association of the Infectious Diseases Society of America. MMWR Recomm Rep. 2003; 52: 1-24. Available at: http://www.cdc.gov/mmwr/preview/mmwrhtml/rr5212a1.htm. Accessed December 1, 2014.
18. Centers for Disease Control and Prevention. Recommendations for partner services programs for HIV infection, syphilis, gonorrhea, and chlamydial infection. MMWR Recomm Rep. 2008; 57: 1-64.
19. Marks G, Richardson JL, Crepaz N, et al. Are HIV care providers talking with patients about safer sex and disclosure? A multi-clinic assessment. AIDS. 2002; 16: 1953-1957.
20. Richardson JL, Milam J, McCutchan A, et al. Effect of brief safer-sex counseling by medical providers to HIV-1 seropositive patients: a multiclinic assessment. AIDS. 2004; 18: 1179-1186.
21. Murname PM, Hughes JP, Celum C, et al. Using plasma viral load to guide antiretroviral therapy initiation to prevent HIV-1 transmission. PLoS One. 2010; 7: e51192.
22. Porco TC, Martin JN, Page-Shafer KA, et al. Decline in HIV infectivity following the introduction of highly active antiretroviral therapy. AIDS 2004; 18: 81-88.
23. Jarzebowski W, Caumes E, Dupin N, et al; FHDH-ANRS CO4 Study Team. Effect of early syphilis infection on plasma viral load and CD4 cell count in human immunodeficiency virus-infected men: results from the FHDH-ANRS CO4 cohort. Arch Intern Med. 2012; 172: 1237-1243.
24. Buchacz K, Patel P, Taylor M, et al. Syphilis increases HIV viral load and decreases CD4 cell counts in HIV-infected patients with new syphilis infections. AIDS. 2004; 18: 2075-2079.
25. Taylor MM, Schillinger JA, Furness BW, et al. Gonorrhea infections diagnosed among persons living with HIV/AIDS: identifying opportunities for integrated prevention services in New York City, Washington, DC, Miami/Dade County, and Arizona. J Acquir Immune Defic Syndr. 2013; 64: 115-120.
26. Centers for Disease Control and Prevention. Monitoring selected national HIV prevention and care objectives by using HIV surveillance data-United States and 6 U.S. dependent areas-2010. HIV Surveillance Supplemental Report. 2012; 17(No. 3, part A). http://www.cdc.gov/hiv/topics/surveillance/resources/reports/. Published June 2012. Accessed May 20, 2013.
27. Code of Federal Regulations. Basic HHS policy for protection of human research subjects. Title 45. ?46.101. Available at: http://www.hhs.gov/ohrp/humansubjects/guidance/45cfr46.html#46.101(b)(1). Accessed June 17, 2014.
28. Centers for Disease Control and Prevention. Distinguishing public health research and public health nonresearch policy. CDC-SA-2010-02. 2010: 5: 4-5.
29. Logistic Regression Examples Using the SAS System, Version 6. 1st ed. Cary, NC: SAS Inc; 1995: 51-66.
30. Beer L, Heffelfinger J, Frazier E, et al. Use of and adherence to antiretroviral therapy in a large U.S. sample of HIV-infected adults in care, 2007-2008. Open AIDS J. 2012; 6: 213-223.
31. Centers for Disease Control and Prevention. Interim guidance: preexposure prophylaxis for the prevention of HIV infection in men who have sex with men. MMWR Recomm Rep. 2011; 60: 65-68.
32. Udeagu CC, Webster TR, Bocour A, et al. Lost or just not following up: public health effort to re-engage HIV-infected persons lost to follow-up into HIV medical care. AIDS. 2013; 27: 2271-2279.
33. Sabharwal CJ, Braunstein SL, Robbins RS, et al. Optimizing the use of surveillance data for monitoring the care status of persons recently diagnosed with HIV in NYC. J Acquir Immune Defic Syndr. 2014; 65: 571-578.
34. Gardner EM, McLees MP, Steiner JF, et al. The spectrum of engagement in HIV care and its relevance to test-and-treat strategies for prevention of HIV infection. Clin Infect Dis. 2011; 52: 793-800.
35. Ryan White HIV/AIDS Program Part a Manual. Available at: http://hab. hrsa.gov/tools2/PartA/parta/ptAsec7chap1.htm#SecVIIChap1e. Accessed February 12, 2014.
36. Lin JS, Whitlock E, O'Connor E, et al. Behavioral counseling to prevent sexually transmitted infections: a systematic review for the U.S. Preventive Task Force. Ann Int Med. 2008; 149: 497-508.
37. Taylor MM, McClain T, Javanbakht M, et al. STD testing protocols, STD testing and discussion of sexual behaviors in HIV clinics in Los Angeles. Sex Transm Dis. 2005; 32: 341-345.
38. Myers JJ, Steward WT, Charlebois E, et al. Written clinic procedures enhance delivery of HIV "Prevention with Positives" counseling in primary health care settings. J Acquir Immune Def Syndr. 2004; 37: S95-S100.
39. Callander D, Baker D, Chen M, et al. Including syphilis testing as partner of standard HIV management checks and improved syphilis screening in primary care. Sex Trans Dis. 2013; 40: 338-340.
40. Politch JA, Mayer KH, Welles SL, et al. Highly active antiretroviral therapy does not completely suppress HIV in semen of sexually active HIV-infected men who have sex with men. AIDS. 2012; 26: 1535-1543.
41. Zuckerman RA, Whittington WL, Celum CL, et al. Higher concentration of HIV RNA in rectal mucosa secretions than in blood and seminal plasma, among men who have sex with men, independent of antiretroviral therapy. J Infect Dis. 2004; 190: 156-161.
42. Baggaley RF, White RG, Boily MC. HIV transmission risk through anal intercourse: systematic review, meta-analysis and implications for HIV prevention. Int J Epidemiol. 2010; 39: 1048-1063.
43. Holmes K. Sexually Transmitted Diseases. New York, NY: McGraw Hill; 1999: 479-485.
44. Ostrow DG, DiFranceisco WJ, Chmiel JS, et al. A case-control study of human immunodeficiency virus type 1 seroconversion and risk-related behaviors in the Chicago MACS/CCS Cohort, 1984-1992. Multicenter AIDS Cohort Study. Coping and Change Study. Am J Epidemiol. 1995; 142: 875-883.
45. Panel on Antiretroviral Guidelines for Adults and Adolescents. Guidelines for the Use of Antiretroviral Agents in HIV-1-infected Adults and Adolescents. Section E1. Department of Health and Human Services. Available at: http://aidsinfo.nih.gov/contentfiles/lvguidelines/AdultandAdolescentGL.pdf. Accessed October 1, 2013.
46. Centers for Disease Control and Prevention. Sexually Transmitted Disease Surveillance, 2001. Atlanta, GA: U.S. Department of Health and Human Services; 2002.
47. Centers for Disease Control and Prevention. Sexually Transmitted Disease Surveillance 2012. Atlanta, GA: U.S. Department of Health and Human Services; 2013.
48. Centers for Disease Control and Prevention. Program Collaboration and Service Integration: Enhancing the Prevention and Control of HIV/AIDS, Viral Hepatitis, Sexually Transmitted Diseases, and Tuberculosis in the United States. Available at: http://www.cdc.gov/nchhstp/ProgramIntegration/docs/207181-C-NCHHSTP-PCSI%20WhitePaper-508c.pdf. Accessed September 14, 2012.